Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.
Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.
The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.
The FDA approved first-time generics for Xeljanz, two COPD medications, and more.
A joint statement announces that at this time, vaccinated adults are protected from the Delta variant.
Wegovy (semaglutide) and sotrovimab will soon be available.
A new 8 mg naloxone nasal spray will soon be available, which is the largest naloxone dose approved by the FDA to date.
After reviewing six rare cases of blood clots after 7 million doses, current data indicates the vaccine is safe.
A new 500mg injection will soon be available.
A novel bupivacaine formulation works as a 72-hour local anesthetic following shoulder surgery.
New data from a safety trial creates concern surrounding the rheumatoid arthritis drug.
